Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
2m
Novo Nordisk: Oral Semaglutide Reduces Risk Of Cardiovascular Events In Phase 3 Trial
Novo Nordisk A/S (NVO) announced Monday the headline results from the SOUL cardiovascular outcomes trial, which achieved its primary ...
Medical News Today
1d
Semaglutide boosts heart health, weight loss but may lead to gut problems
A new meta-analysis confirms that semaglutide drugs like Ozempic are not only effective for weight loss, but can also protect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Liberty win first WNBA title
Reaches tentative union deal
Ceasefire talks in Beirut
The Vessel to reopen
Trump's Pennsylvania rally
Baldwin returns to 'SNL'
WWII code talker dies
American activist Wair dies
Ferry dock collapses in GA
Helicopter hits radio tower
Albany State shooting
US probing documents leak
Opens up on Russian camp
Boat rider arrested in FL
Southern Miss fires coach
Oakland fire burns homes
NYC Halloween dog parade
Hezbollah assets targeted
New Mexico flash flooding
Gold hits fresh high
Advance to World Series
Wins third PGA Tour title
Rock & Roll HOF '24 class
CVS workers strike
Launches OneWeb mission
Postpones US tour
Orionids meteor shower
US deficit reaches $1.8T
Oscar makes landfall
Feedback